Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stronger legs, fewer shin splints? new study tests simple prevention

NCT ID NCT07256808

Prevention Sponsor: Rowan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a 10-week heavy leg strengthening program could help prevent medial tibial stress syndrome (MTSS), commonly known as shin splints, in college track and field runners. Twenty-six athletes were split into two groups: one did the strengthening exercises plus their regular training, while the other only did regular training. Researchers tracked symptoms and muscle properties over the season to see if the program made a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

Sep 2023

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Collegiate athletes on the Indoor Track and Field team. * Athletes must participate in at least one of the following: * 60m-800m events (including hurdles) * jumping events (including pole vault) Exclusion Criteria: * Subjects who have a history of musculoskeletal or neurologic conditions * Who take medications that affect muscle tone * Who have a body mass index \>30.0 kg/m2 were excluded to screen to prevent adipose tissue from skewing the measurements. * Any subject with any fractures, sprains, or strains of the lower extremities were excluded. * Any subject with active MTSS, stress fracture, or other lower leg pathology symptoms at the time the initial survey was administered were excluded. * Any athlete who does not participate in the 60m-800m events (including hurdles), or who does not participate in jumping events (including pole vault) were excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Medial tibial stress syndrome are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Medial Tibial Stress Syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Medial tibial stress syndrome

Contacts and locations

Locations

  • Rowan University

    Glassboro, New Jersey, 08028, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.